Abstract: Methods of treating a human infected with human immunodeficiency virus (HIV), such as a human with AIDS, with the purina nucleotides 2',3'-dideoxy-2'-beta-fluoroadenosine (FddA) and 2',3'-dideoxy-2'-beta-fluoroinosine (FddI) are disclosed. These nucleotides are stable in an acid environment and thus can be used for oral administration. Methods of inhibiting human immunodeficiency virus replication in a human T cell using these purina nucleotides are also disclosed.
Type:
Grant
Filed:
November 10, 1992
Date of Patent:
October 15, 1996
Assignee:
The United States of America as represented by the Department of Health and Human Services
Inventors:
Victor E. Marquez, John S. Driscoll, Christopher K-H. Tseng, James A. Kelley, David G. Johns, Hiroaki Mitsuya
Abstract: Purine nucleosides active against human immunodeficiency virus which are substituted at the 2'-position by a strong electronegative group such as fluorine are stable in an acid environment and thus can be used for oral administration.
Type:
Grant
Filed:
September 19, 1991
Date of Patent:
February 27, 1996
Assignee:
The United States of America as represented by the Department of Health and Human Services
Inventors:
Victor E. Marquez, John S. Driscoll, Christopher K-H. Tseng, James A. Kelley, David G. Johns, Hiroaki Mitsuya
Abstract: Compounds having the structure: ##STR1## wherein B represents a purine, 7-deazapurine, or pyrimidine moiety covalently bonded to the C.sup.1' -position of the sugar moiety, provided that when B is purine or 7-deazapurine, it is attached at the N.sup.9 -position of the purine or 7-deazapurine and when B is pyrimidine, it is attached at the N.sup.
Type:
Grant
Filed:
December 8, 1987
Date of Patent:
July 12, 1994
Assignee:
Yale University
Inventors:
David C. Ward, Pennina R. Langer, Alexander A. Waldrop, III
Abstract: Gene expression in a cell can be regulated or inhibited by incorporating into or associating with the genetic material of the cell a non-native nucleic acid sequence which is transcribed to produce an mRNA which is complementary to and capable of binding to the mRNA produced by the genetic material of said cell.
Type:
Grant
Filed:
June 21, 1990
Date of Patent:
December 21, 1993
Assignee:
Research Foundation of State University of New York
Abstract: Gene expression in a cell can be regulated or inhibited by incorporating into or associating with the genetic material of the cell a non-native nucleic acid sequence which is transcribed to produce an mRNA which is complementary to and capable of binding to the mRNA produced by the genetic material of said cell.
Type:
Grant
Filed:
April 10, 1992
Date of Patent:
May 4, 1993
Assignee:
The Research Foundation of State University of New York
Abstract: Gene expression in a cell can be regulated or inhibited by incorporating into or associating with the genetic material of the cell a non-native nucleic acid sequence which is transcribed to produce an mRNA which is complementary to and capable of binding to the mRNA produced by the genetic material of said cell.
Type:
Grant
Filed:
November 15, 1989
Date of Patent:
March 2, 1993
Assignee:
The Research Foundation of State University of New York